Clinical trials · Spokane, WA
Small Lymphocytic Lymphoma clinical trials in Spokane
We’re tracking 7 recruiting small lymphocytic lymphoma studies with a site in or near Spokane — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Spokane
- NCT06973187RecruitingPhase 3
Comparing two drugs for CLL or SLL after prior treatment
This trial tests a new drug (BGB-16673) against another drug (pirtobrutinib) for people with CLL or SLL that hasn't responded to or has come back after a prior BTK inhibitor treatment. The goal is to see which drug is more effective and safe.
Spokane, WashingtonAges 18 years+ - NCT07342478RecruitingPhase 3
Comparing two BTK inhibitors for CLL/SLL after prior treatment
This study compares two oral targeted therapies, rocbrutinib and pirtobrutinib, for people with CLL or SLL whose disease has come back or stopped responding after treatment with a covalent BTK inhibitor (like ibrutinib). The goal is to see which drug works better and has fewer side effects.
Spokane, WashingtonAges 18 years+ - NCT05254743RecruitingPhase 3
Pirtobrutinib versus ibrutinib for CLL or SLL
This Phase 3 trial compares two oral medicines—pirtobrutinib and ibrutinib—in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who need treatment. It’s designed to see which drug works better and is easier to take, especially for people with a specific genetic change in the cancer (17p deletion).
Spokane, WashingtonAges 18 years+ - NCT05947851RecruitingPhase 3
Nemtabrutinib plus venetoclax versus standard add-on therapy
This Phase 3 study tests whether adding nemtabrutinib to venetoclax works better than the usual next treatment approach (venetoclax plus rituximab) in people with relapsed or treatment-resistant CLL/SLL. It may help by improving how well the cancer responds after at least one prior therapy.
Spokane, WashingtonAges 18 years+ - NCT06136559RecruitingPhase 3
Study of Nemtabrutinib vs ibrutinib or acalabrutinib for untreated CLL/SLL
This trial tests a new drug, nemtabrutinib, against two standard treatments for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who haven't had treatment yet. The goal is to see if the new drug works better at controlling the disease.
Spokane, WashingtonAges 18 years+ - NCT04728893RecruitingPhase 2
Nemtabrutinib for blood cancers after prior treatment
This Phase 2 trial tests nemtabrutinib (MK-1026), an oral medicine, in people with certain blood cancers that have come back or didn’t respond to earlier treatments. It aims to see how well the drug works and whether it is safe.
Spokane, WashingtonAges 18 years+ - NCT04269902RecruitingPhase 3
Early treatment check for high-risk CLL/SLL
This Phase 3 trial studies an early treatment approach for people with high-risk CLL or SLL who have not yet needed standard therapy. It aims to see if treating earlier can improve outcomes while keeping side effects manageable.
Post Falls, IdahoAges 18 years+
Hear when a new Small Lymphocytic Lymphoma trial opens near Spokane, WA
We’ll email you when one opens near Spokane, WA — at most once a week, no account needed, unsubscribe anytime.
Small Lymphocytic Lymphoma trials in other cities
Where these studies are running near Spokane
Institutions with a site for the recruiting small lymphocytic lymphoma studies listed above.
- Medical Oncology Associates, PS · 5 studies
- Kootenai Clinic Cancer Services - Post Falls
- Kootenai Health - Coeur d'Alene
- MultiCare Institute for Research and Innovation
- Summit Cancer Centers
What taking part in a small lymphocytic lymphoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting small lymphocytic lymphoma studies in Washington.
Common questions
- Are there small lymphocytic lymphoma clinical trials near Spokane?
- Yes. We're currently tracking 7 recruiting small lymphocytic lymphoma studies with a site near Spokane, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a small lymphocytic lymphoma study near Spokane?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Spokane to take part?
- Not necessarily. These studies have a site near Spokane, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a small lymphocytic lymphoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New small lymphocytic lymphoma studies open near Spokane regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.